Advanced in Tethered Cord Syndrome

Dr. Steven H. Applebaum

Hematology Oncology | Hematology | Oncology
The Regents Of The University Of California
2020 Santa Monica Blvd, Suite 210, 
Santa Monica, CA 
Offers Telehealth
Advanced in Tethered Cord Syndrome
The Regents Of The University Of California
2020 Santa Monica Blvd, Suite 210, 
Santa Monica, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Steven Applebaum is a Hematologist Oncology specialist and a Hematologist in Santa Monica, California. Dr. Applebaum is rated as an Advanced provider by MediFind in the treatment of Tethered Cord Syndrome. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Anemia.

His clinical research consists of participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in CA
Hospital Affiliations
Huntington Hospital
USC Verdugo Hills Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
2020 Santa Monica Blvd, Suite 210, Santa Monica, CA 90404
Other Locations
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
625 S Fair Oaks Ave, Suite 320, Pasadena, CA 91105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
Enrollment Status: Active_not_recruiting
Publish Date: October 29, 2025
Intervention Type: Other, Biological, Drug
Study Drugs: Trastuzumab Emtansine, Tucatinib
Study Phase: Phase 3
View 1 Less Clinical Trial
Similar Doctors
Distinguished in Tethered Cord Syndrome
Dr. Solomon I. Hamburg
Hematology Oncology | Hematology | Oncology
Distinguished in Tethered Cord Syndrome
Dr. Solomon I. Hamburg
Hematology Oncology | Hematology | Oncology

The Regents Of The University Of California

2020 Santa Monica Blvd, Suite 210, 
Santa Monica, CA 
 (0.1 miles away)
310-458-2381
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Solomon Hamburg is a Hematologist Oncology specialist and a Hematologist in Santa Monica, California. Dr. Hamburg is rated as a Distinguished provider by MediFind in the treatment of Tethered Cord Syndrome. His top areas of expertise are Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), and Severe Congenital Neutropenia.

Experienced in Tethered Cord Syndrome
Dr. Eddie H. Hu
Hematology | Oncology | Hematology Oncology
Experienced in Tethered Cord Syndrome
Dr. Eddie H. Hu
Hematology | Oncology | Hematology Oncology

The Regents Of The University Of California

1411 S Garfield Ave, Suite 200, 
Alhambra, CA 
 (20.7 miles away)
626-588-2825
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eddie Hu is a Hematologist and an Oncologist in Alhambra, California. Dr. Hu is rated as a Distinguished provider by MediFind in the treatment of Tethered Cord Syndrome. His top areas of expertise are Breast Cancer, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

Experienced in Tethered Cord Syndrome
Dr. Daniel J. Lieber
Hematology Oncology | Hematology | Oncology
Experienced in Tethered Cord Syndrome
Dr. Daniel J. Lieber
Hematology Oncology | Hematology | Oncology
2001 Santa Monica Blvd, Suite 560W, 
Santa Monica, CA 
 (0.1 miles away)
310-582-7900
Languages Spoken:
English, Spanish
See accepted insurances

Daniel Lieber is a Hematologist Oncology specialist and a Hematologist in Santa Monica, California. Dr. Lieber is rated as an Advanced provider by MediFind in the treatment of Tethered Cord Syndrome. His top areas of expertise are Polycythemia Vera, Non-Hodgkin Lymphoma, Richter Syndrome, and Chronic Lymphocytic Leukemia (CLL).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Applebaum's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile